Editorial: Advancement of chemotherapy in breast cancer: predictive markers, resistance mechanism and therapeutic strategies - Top-Institutions - MDSpire

Editorial: Advancement of chemotherapy in breast cancer: predictive markers, resistance mechanism and therapeutic strategies

  • By

  • Richard Beatson

  • Jinhai Deng

  • Teng Pan

  • Zhendong Shi

  • Ming Zhao

  • July 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #2

    MD Anderson’s Institute for Data Science in Oncology (IDSO)
    MD Anderson’s Institute for Data Science in Oncology (IDSO)

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    Department of Breast Medical Oncology
    Department of Breast Medical Oncology

    Houston, TX

    Key Differentiators

    • Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology

Original Source(s)

Editorial: Advancement of chemotherapy in breast cancer: predictive markers, resistance mechanism and therapeutic strategies

  • by Richard Beatson, Jinhai Deng, Teng Pan, Zhendong Shi, Ming Zhao

  • July 3, 2026

Related Content

Case report: Secretory carcinoma of the breast with ETV6-NTRK3 fusion: clinicopathological features and molecular confirmation by FISH in two cases

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

Physicians’ attitudes and perceptions toward the integration of artificial intelligence into pediatric hematology–oncology in Saudi Arabia